论文部分内容阅读
目的观察雾化吸入特布他林治疗哮喘的临床效果和安全性。方法将哮喘患者120例随机分为两组,两组均给予常规治疗,对照组在常规治疗的基础上加用布地奈德雾化吸入治疗(n=60),观察组在对照组基础上加用特布他林雾化吸入治疗(n=60)。治疗后比较两组症状改善时间。结果治疗后观察组与对照组比较,肺功能参数及临床症状均有显著改善(P<0.01),观察组症状改善时间明显快于对照组,两组间各对应指标相比较差异均有统计学意义(P<0.01)。结论特布他林联合布地奈德雾化吸入治疗哮喘临床效果显著,值得临床推广应用。
Objective To observe the clinical effect and safety of inhalation of terbutaline in the treatment of asthma. Methods One hundred and twenty patients with asthma were randomly divided into two groups. Both groups were given routine treatment. The control group was treated with inhaled budesonide inhalation (n = 60) on the basis of routine treatment. The observation group was added on the basis of the control group Treatment with terbutaline inhalation (n = 60). After treatment, the two groups were compared to improve the symptoms. Results After treatment, the lung function parameters and clinical symptoms were significantly improved in the observation group and the control group (P <0.01), and the symptom improvement time in the observation group was significantly faster than that in the control group. There were statistically significant differences in the corresponding indicators between the two groups Significance (P <0.01). Conclusion Terbutaline combined with budesonide inhalation treatment of asthma significant clinical effect, it is worthy of clinical application.